Curative Biosciences (Curative Biosciences) Net Income From Continuing Operations : $-0.52 Mil (TTM As of Mar. 2018)

View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Curative Biosciences's net income from continuing operations for the three months ended in Mar. 2018 was $-0.03 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2018 was $-0.52 Mil.

Curative Biosciences Net Income From Continuing Operations Historical Data

The historical data trend for Curative Biosciences's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences Net Income From Continuing Operations Chart

Curative Biosciences Annual Data

Trend

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Net Income From Continuing Operations

Get a 7-Day Free Trial

-6.64

-30.00

-3.37

-1.66

-0.05

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Net Income From Continuing Operations	Get a 7-Day Free Trial															-	-0.02	-0.02	-0.45	-0.03

Curative Biosciences Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

Curative Biosciences (Curative Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131

Website

http://www.CurativeBio.com

Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines